Loading stock data…
Clover Health Investments (CLOV)
$5.31-0.10 (-1.85%)
Market ClosedLast close Jun 29
Clover Health Investments, Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Clover Health Investments, Corp. in the Healthcare sector is trading at $5.31 with a market capitalization of $2.6B. Wall Street consensus targets $4.15 (3 analysts), implying a -21.8% move over the next 12 months. The stock is currently near its 52-week high of $5.59, remaining 91.0% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -21.8% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $749.19M↑ | $487.71M↓ | $496.65M↑ | $477.62M↑ | $462.33M |
| Gross Profit | $159.54M↑ | $74.21M↑ | $73.18M↓ | $99.63M↓ | $108.89M |
| Operating Income | $27.33M↑ | -$49.32M↓ | -$24.38M↓ | -$10.56M↓ | -$1.27M |
| Net Income | $27.33M↑ | -$49.32M↓ | -$24.38M↓ | -$10.58M↓ | -$1.27M |
Peer Comparison
JNJUNHPFE
Fundamentals
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.63B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-16.78%
Volume
Today's trading volume
8.45M
Recent News
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.
This healthcare technology firm, focused on Medicare Advantage plans, reported a notable insider sale amid muted stock performance.
1 Russell 2000 Stock to Own for Decades and 2 We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Clover Health (CLOV): 3 Reasons We Love This Stock
Clover Health has been on fire lately. In the past six months alone, the company’s stock price has rocketed 92.7%, setting a new 52-week high of $5.01 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Jim Cramer Says Clover Health (CLOV) Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS
Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided […]
Clover Health (CLOV)Hits Fresh Peak on Unexpected CMS Rating
Clover Health Investments Corp. (NASDAQ:CLOV) is one of the 10 Stocks Surviving Market Slaughter. Clover Health extended its winning streak to a third straight day on Wednesday, to hit a new all-time high, as investors loaded portfolios after the company earned a rating upgrade from the Centers for Medicare and Medicaid Services (CMS). In intra-day […]